Article

jdsupra.com on 2022-07-06 16:25

Unpacking Averages: Common Root Causes Driving Medical Device Recalls

Recalls have always been a bit of a double-edged sword. Obviously, companies hate recalls because a recall means their products are defective in some ...

FDA

Related news

Unpacking Averages: Popular Ways to Combine Device Functionality jdsupra.com
Unpacking Averages: Likelihood of FDA Medical Device Inspections jdsupra.com
North Dakota , United States
Unpacking Averages: Device Inspection Citations That Frequently Precede Warning Letters jdsupra.com
United Kingdom
Unpacking Averages: Violations Found in Medical Device Warning Letters jdsupra.com
United Kingdom
Unpacking Averages: Analyzing FDA Device-Related Citizens Petitions by Topic jdsupra.com
United States
Unpacking Averages: Analyzing Descriptions from Cardiovascular Device Adverse Events jdsupra.com
United Kingdom
Unpacking Averages: Assessing Whether FDA’s Breakthrough Device Designation Is Helpful jdsupra.com
Unpacking Averages: Adverse Events for Device-Lead Combination Products jdsupra.com
Unpacking Averages: Analyzing the Relationship Between MDRs and Recalls jdsupra.com
Unpacking Averages: Finding Medical Device Predicates Without Using FDA’s 510(k) Database jdsupra.com
Unpacking Averages: Intended Use Words Most Common to Devices That Require Clinical Trials jdsupra.com
Unpacking Averages: Device Manufacturers Should Use the Newly Released Demographic Data in MDRs to Ensure Their Devices Are Not Disproportionately Hurting Minorities jdsupra.com
United States
Unpacking Averages: FDA’s Extraordinary Delay in Resolving Citizen Petitions jdsupra.com
Florida , A Florida , Lens
Unpacking Averages: Analyzing FDA’s Performance in Finalizing Guidance Documents jdsupra.com
Unpacking Averages: Connecting Published Clinical Trials with FDA Drug Approvals jdsupra.com
United Kingdom
Unpacking Averages: FDA Review Time for 510(k)s jdsupra.com
Unpacking Averages: Using NLP to Assess FDA’s Compliance with Notice and Comment in Guidance Development jdsupra.com
Chicago , Illinois , United Kingdom , France
Unpacking Averages: Assessing the Racial Composition of Drug Clinical Trial Subjects jdsupra.com
Unpacking Averages: Assessing FDA’s Performance Categorizing New Diagnostic Tests Under CLIA jdsupra.com
Reg
Unpacking Averages: Exploring New Data on FDA Responses to FOIA Requests jdsupra.com
High Level